These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37701331)

  • 1. Classical phenylketonuria presenting as maternal PKU syndrome in the offspring of an intellectually normal woman.
    Alghamdi MA; O'Donnell-Luria A; Almontashiri NA; AlAali WY; Ali HH; Levy HL
    JIMD Rep; 2023 Sep; 64(5):312-316. PubMed ID: 37701331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undiagnosed maternal phenylketonuria: own clinical experience and literature review.
    Bouchlariotou S; Tsikouras P; Maroulis G
    J Matern Fetal Neonatal Med; 2009 Oct; 22(10):943-8. PubMed ID: 19557660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The maternal phenylketonuria syndrom--still current problem].
    Didycz B; Domagała L; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic etiology and clinical challenges of phenylketonuria.
    Elhawary NA; AlJahdali IA; Abumansour IS; Elhawary EN; Gaboon N; Dandini M; Madkhali A; Alosaimi W; Alzahrani A; Aljohani F; Melibary EM; Kensara OA
    Hum Genomics; 2022 Jul; 16(1):22. PubMed ID: 35854334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote.
    Kleiman S; Vanagaite L; Bernstein J; Schwartz G; Brand N; Elitzur A; Woo SL; Shiloh Y
    J Med Genet; 1993 Apr; 30(4):284-8. PubMed ID: 8487271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal Phenylketonuria Collaborative Study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae.
    Rouse B; Azen C; Koch R; Matalon R; Hanley W; de la Cruz F; Trefz F; Friedman E; Shifrin H
    Am J Med Genet; 1997 Mar; 69(1):89-95. PubMed ID: 9066890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal phenylketonuria in Turkey: outcomes of 71 pregnancies and issues in management.
    Yıldız Y; Sivri HS
    Eur J Pediatr; 2019 Jul; 178(7):1005-1011. PubMed ID: 31053953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Singleton and twin pregnancies of PKU patients - individual variability of phenylalanine tolerance: experience of a single treatment center (Preliminary report)].
    Żółkowska J; Hozyasz KK; Nowacka M
    Dev Period Med; 2017; 21(4):344-360. PubMed ID: 29291362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal phenylketonuria: a metabolic teratogen.
    Levy HL; Ghavami M
    Teratology; 1996 Mar; 53(3):176-84. PubMed ID: 8761885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylketonuria: an inborn error of phenylalanine metabolism.
    Williams RA; Mamotte CD; Burnett JR
    Clin Biochem Rev; 2008 Feb; 29(1):31-41. PubMed ID: 18566668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylketonuria: screening, treatment and maternal PKU.
    Matalon R; Michals K
    Clin Biochem; 1991 Aug; 24(4):337-42. PubMed ID: 1959225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nutrition in pregnancy with phenylketonuria and birth defects.
    Matalon KM; Acosta PB; Azen C
    Pediatrics; 2003 Dec; 112(6 Pt 2):1534-6. PubMed ID: 14654660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic phenotyping in phenylketonuria reveals disease clustering independently of metabolic control.
    Moritz L; Klotz K; Grünert SC; Hannibal L; Spiekerkoetter U
    Mol Genet Metab; 2023 Mar; 138(3):107509. PubMed ID: 36791482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal PKU: Defining phenylalanine tolerance and its variation during pregnancy, according to genetic background.
    Caletti MT; Bettocchi I; Baronio F; Brodosi L; Cataldi S; Petroni ML; Cassio A; Marchesini G
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):977-983. PubMed ID: 32409273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal phenylketonuria syndrome: studies in mice suggest a potential approach to a continuing problem.
    Zeile WL; McCune HC; Musson DG; O'Donnell B; O'Neill CA; Tsuruda LS; Zori RT; Laipis PJ
    Pediatr Res; 2018 Apr; 83(4):889-896. PubMed ID: 29278642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untreated PKU patients without intellectual disability:
    Klaassen K; Djordjevic M; Skakic A; Kecman B; Drmanac R; Pavlovic S; Stojiljkovic M
    Mol Genet Metab Rep; 2021 Dec; 29():100822. PubMed ID: 34900593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: Results from a survey with 228 patients and their caregivers.
    Martins AM; Pessoa ALS; Quesada AA; Ribeiro EM
    Mol Genet Metab Rep; 2020 Sep; 24():100624. PubMed ID: 32742934
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.